Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Bar

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Journal of the American Academy of Dermatology|June 6, 2022
Accuracy of digital data-based diagnoses: A single-center prospective comparative trialDana Shalmon, Eran Ellenbogen, Yehonatan Kaplan, et al.
Nano Letters|October 21, 2025
Tracking Molecular Shear at Metal Surfaces Using Enhanced Lamb Wave Scattering in Plasmonic NanocavitiesAlexandra Boehmke, Jonathan Bar-David, Sarah Sibug-Torres, et al.
Allergy|January 6, 2025
Skin Tape Stripping Reveals Distinct Biomarker Profiles in Chronic Hand Eczema of Patients With and Without Comorbid Atopic DermatitisJonathan Bar, Ester Del Duca, Eden David, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|May 16, 2023
Pediatric Contact Dermatitis: A 10-Year Multicenter Retrospective StudyDan Slodownik, Jonathan Bar, Michal Solomon, et al.
Clinical and Experimental Dermatology|March 27, 2022
Superimposed type 2 segmental atopic dermatitis: case series and review of the literatureEfrat Bar-Ilan, Jacob Mashiah, Ronen Alkalay, et al.
Allergy|June 27, 2025
OX40 and Regulatory Marker Alterations in Lesional and Non-Lesional Keloid TissuesJonathan Bar, Eden David, Ester Del Duca, et al.
Clinical and Experimental Dermatology|November 14, 2024
Real-world efficacy and safety of dupilumab for paediatric atopic dermatitis: a multicentre retrospective studyEitan Pirov, Vered Molho-Pessach, Eran Cohen-Barak, et al.
The Journal of Allergy and Clinical Immunology|September 30, 2023
Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligoEmma Guttman-Yassky, Ester Del Duca, Joel Correa Da Rosa, et al.
ACS Nano|June 18, 2026
How the Electrochemical Double Layer Manipulates Molecule-Metal InteractionsTabitha Jones, Minho M Kim, Sarah May Sibug-Torres, et al.
Archives of Dermatological Research|July 18, 2024
Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligoYuji Yamaguchi, Elena Peeva, Ester Del Duca, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of the American Academy of Dermatology|June 6, 2022
Accuracy of digital data-based diagnoses: A single-center prospective comparative trialDana Shalmon, Eran Ellenbogen, Yehonatan Kaplan, et al.
Nano Letters|October 21, 2025
Tracking Molecular Shear at Metal Surfaces Using Enhanced Lamb Wave Scattering in Plasmonic NanocavitiesAlexandra Boehmke, Jonathan Bar-David, Sarah Sibug-Torres, et al.
Allergy|January 6, 2025
Skin Tape Stripping Reveals Distinct Biomarker Profiles in Chronic Hand Eczema of Patients With and Without Comorbid Atopic DermatitisJonathan Bar, Ester Del Duca, Eden David, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|May 16, 2023
Pediatric Contact Dermatitis: A 10-Year Multicenter Retrospective StudyDan Slodownik, Jonathan Bar, Michal Solomon, et al.
Clinical and Experimental Dermatology|March 27, 2022
Superimposed type 2 segmental atopic dermatitis: case series and review of the literatureEfrat Bar-Ilan, Jacob Mashiah, Ronen Alkalay, et al.
Allergy|June 27, 2025
OX40 and Regulatory Marker Alterations in Lesional and Non-Lesional Keloid TissuesJonathan Bar, Eden David, Ester Del Duca, et al.
Clinical and Experimental Dermatology|November 14, 2024
Real-world efficacy and safety of dupilumab for paediatric atopic dermatitis: a multicentre retrospective studyEitan Pirov, Vered Molho-Pessach, Eran Cohen-Barak, et al.
The Journal of Allergy and Clinical Immunology|September 30, 2023
Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligoEmma Guttman-Yassky, Ester Del Duca, Joel Correa Da Rosa, et al.
ACS Nano|June 18, 2026
How the Electrochemical Double Layer Manipulates Molecule-Metal InteractionsTabitha Jones, Minho M Kim, Sarah May Sibug-Torres, et al.
Archives of Dermatological Research|July 18, 2024
Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligoYuji Yamaguchi, Elena Peeva, Ester Del Duca, et al.
Pageof 5